No Data
No Data
After Losing 56% in the Past Year, Zura Bio Limited (NASDAQ:ZURA) Institutional Owners Must Be Relieved by the Recent Gain
New Analyst Forecast: $ZURA Given $3.0 Price Target
H.C. Wainwright Maintains Zura Bio(ZURA.US) With Hold Rating, Cuts Target Price to $3
Zura Bio Is Maintained at Neutral by HC Wainwright & Co.
Cautious Hold Rating for Zura Bio Amid Financial Challenges and Clinical Uncertainties
Express News | Zura Bio Limited : H.c. Wainwright Cuts Target Price to $3 From $5